Gene · 5052
Papers3,897
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,897
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PRDX1 as a novel urinary biomarker for bladder cancer: Development of an integrated fiber optic sensing platform. | Talanta | 2027 | 42349259 | PubTator, text mining | PubMed |
| Research progress on the characterization, evolution and functions of molluscan peroxiredoxins. | Dev Comp Immunol | 2026 | 42810604 | PubTator, text mining | PubMed |
| Chemogenomic maps reveal a PRDX1-dependent iron-damage axis in the DNA damage response. | Nat Chem Biol | 2026 | 42711491 | PubTator, text mining | PubMed |
| PRDX1 facilitates USP7-dependent stabilization of SCD1 and promotes bladder cancer progression. | Cell Signal | 2026 | 42705398 | PubTator, text mining | PubMed |
| Identification of Immune Response-Related Proteomic Biomarkers in Moyamoya Disease Using Serum Olink Proteomics. | J Proteome Res | 2026 | 42695863 | PubTator, text mining | PubMed |
| Methodological approach to investigate peroxiredoxin 1 deacetylation by histone deacetylase 6. | Methods Enzymol | 2026 | 42692764 | PubTator, text mining | PubMed |
| Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species. | Science | 2026 | 42691162 | PubTator, text mining | PubMed |
| A peroxiredoxin 1-reactive oxygen species feedback loop modulates nuclear factor kappa B activity in osteoclastogenesis. | Mol Biomed | 2026 | 42658444 | PubTator, text mining | PubMed |
| Molecular Mechanisms Governing Vascular Function in Heart Failure. | Arterioscler Thromb Vasc Biol | 2026 | 42619591 | PubTator, text mining | PubMed |
| Placental PRDX2-VEGFA/ENG network rewiring links oxidative stress to angiogenic failure in preeclampsia: A multi-cohort transcriptomic study. | Comput Biol Chem | 2026 | 42603350 | PubTator, text mining | PubMed |
| Oridonin targets PRDX1 to promote apoptosis by inducing ROS-mediated ER stress and modulating autophagy. | Int J Biol Sci | 2026 | 42524666 | PubTator, text mining | PubMed |
| Oligomer-dependent heme-binding to human peroxiredoxin 1. | Int J Biol Macromol | 2026 | 42501839 | PubTator, text mining | PubMed |
| In-depth monitoring of host cell proteins in influenza vaccines throughout multi-step purification processes. | Vaccine | 2026 | 42501716 | PubTator, text mining | PubMed |
| iTRAQ- and MRM-Based Proteomics Identify Early Injury Biomarkers for Primary Dysfunction After Liver Transplantation. | Ann Transplant | 2026 | 42444103 | PubTator, text mining | PubMed |
| GLI2 confers ferroptosis resistance in bladder cancer by transcriptionally upregulating PRDX1. | Apoptosis | 2026 | 42435244 | PubTator, text mining | PubMed |
| Integrated proteomic profiling and in silico miRNA and lncRNA analysis of glucose-capped fisetin silver nanoparticle-mediated cell proliferation arrest in breast cancer. | 3 Biotech | 2026 | 42404972 | PubTator, text mining | PubMed |
| PRDX1 Suppression Drives Chromium-Induced Hepatotoxicity via Calcium-Mediated Mitochondrial-ER Dysfunction and Ferroptosis. | J Agric Food Chem | 2026 | 42394424 | PubTator, text mining | PubMed |
| Biological responses of human astrocytes (SVGp12) and glioblastoma (A172) cells to dendronized β-cyclodextrin molecular containers: Morphological and molecular insights. | Bioorg Chem | 2026 | 42385392 | PubTator, text mining | PubMed |
| Synthesis and multilevel evaluation of benzimidazole-based anticancer compounds: DNA/serum albumin interaction, and in-depth theoretical insights. | Mol Cell Biochem | 2026 | 42334525 | PubTator, text mining | PubMed |
| Gambogic acid induces cell death via covalent binding with PRDX1 to regulate ER stress and autophagy. | Chin Med | 2026 | 42237349 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5052/papers